Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer.

Okugawa, Yoshinaga; Toiyama, Yuji; Toden, Shusuke; Mitoma, Hiroki; Nagasaka, Takeshi; Tanaka, Koji; Inoue, Yasuhiro; Kusunoki, Masato; Boland, C Richard; Goel, Ajay

Okugawa, Yoshinaga; Toiyama, Yuji; Toden, Shusuke; Mitoma, Hiroki; Nagasaka, Takeshi; Tanaka, Koji; Inoue, Yasuhiro; Kusunoki, Masato; Boland, C Richard; Goel, Ajay.

Afiliação

Okugawa Y; Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.
Toiyama Y; Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.
Toden S; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
Mitoma H; Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.
Nagasaka T; Baylor Institute for Immunology Research, Baylor Research Institute, Baylor Health Care System, Dallas, Texas, USA.
Tanaka K; Department of Gastroenterological Surgery and Surgical Oncology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
Inoue Y; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
Kusunoki M; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
Boland CR; Department of Gastrointestinal and Pediatric Surgery, Division of Reparative Medicine, Institute of Life Sciences, Mie University Graduate School of Medicine, Mie, Japan.
Goel A; Center for Gastrointestinal Cancer Research; Center for Epigenetics, Cancer Prevention and Cancer Genomics, Baylor Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.

Gut ; 66(1): 107-117, 2017 01.

Article em En | MEDLINE | ID: mdl-26475630

Assuntos

Biomarcadores Tumorais/genética; Neoplasias Colorretais/genética; Neoplasias Colorretais/patologia; Recidiva Local de Neoplasia/genética; RNA Nucleolar Pequeno/genética; Idoso; Animais; Anoikis/genética; Linhagem Celular Tumoral; Movimento Celular/genética; Proliferação de Células/genética; Transformação Celular Neoplásica/genética; Intervalo Livre de Doença; Feminino; Técnicas de Silenciamento de Genes; Células HEK293; Humanos; Masculino; Camundongos; Pessoa de Meia-Idade; Invasividade Neoplásica/genética; Metástase Neoplásica; Estadiamento de Neoplasias; Oncogenes; Prognóstico; Taxa de Sobrevida

Palavras-chave

COLORECTAL CANCER

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Biomarcadores Tumorais / RNA Nucleolar Pequeno / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Aged / Animals / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google